US Stocks
/
Traws Pharma, Inc. Share Price

Traws Pharma, Inc. Share Price

NASDAQ: TRAW | Micro Cap
$0.47
-$0.01 (-1.68%) Last updated on 09 Oct, 2026 | 01:23 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Traws Pharma, Inc. Stock Performance

Open
$0.47
Prev. Close
$0.48
Circuit Range
N/A
Day Range
$0.47 - $0.48
Year Range
$0.45 - $3.25
Volume
1,767
Average Traded
$0.47

Traws Pharma, Inc. Share Price Today

As of 9 October 2026, Traws Pharma, Inc.'s share price is $0.47. The stock opened at $0.47, compared to its previous close of $0.48. During today's trading session, Traws Pharma, Inc.'s share price traded between $0.47 and $0.48, with an average price of $0.47. Over the past 52 weeks, the stock has recorded a high of $3.25 and a low of $0.45. In terms of performance, Traws Pharma, Inc.'s share price has declined by 66.69% over the last six months and is down 81.34% on a year-on-year basis.

Traws Pharma, Inc. Share Price Chart

$0.47$0.48
L
Show Current Price
H

Traws Pharma, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.89M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.09
Revenue (TTM)
$2.79B
Return On Equity (TTM)
-989.71%
Profit Margin
246.24%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
14.14%

Traws Pharma, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$3.04-$5.40-$5.69-$2.61
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-77.63%-5.37%54.13%

Traws Pharma, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.23$2.79
Net Profit-$54.67$6.87
Net Profit Margin-23769.57%246.24%
Income ChangeN/A112.57%

About Traws Pharma, Inc.

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib. The company has four clinical programs: (i) tivoxavir marboxil, (ii) ratutrelvir, (iii) narazaciclib (ON 123300), and (iv) rigosertib. It is focused on the development of tivoxavir marboxil and ratutrelvir. The company derives revenue from its collaboration and licensing agreements.

Traws Pharma, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$0.56
$0.47
-21.17%
Sep 2026
$0.56
$0.60
+13.21%
Aug 2026
$0.45
$0.53
+18.04%
Jul 2026
$0.82
$0.45
-45.38%
Jun 2026
$1.47
$0.82
-43.51%
May 2026
$1.45
$1.46
+2.46%
Apr 2026
$1.73
$1.42
-20.67%
Mar 2026
$1.51
$1.79
+9.15%
Feb 2026
$2.04
$1.64
-23.72%
Jan 2026
$1.17
$2.15
+95.45%
Dec 2025
$2.73
$1.10
-59.26%
Nov 2025
$2.57
$2.70
+6.51%

TRAW Share Price FAQs

What is Traws Pharma, Inc. share price today?

chevron-up
Traws Pharma, Inc. share price today is $0.47 as on October 9, 2026 at 1:23 am IST.

What is the 52 week high and 52 week low of Traws Pharma, Inc. stock?

chevron-up
The 52 week high of Traws Pharma, Inc. stock is $3.25, while the 52 week low is $0.45 as of 9 Oct '26.

What is TRAW's market capitalisation today?

chevron-up
TRAW market capitalisation is $3.89M as of October 9, 2026, at 2:58 pm IST.

What is TRAW's net income for the last quarter?

chevron-up
TRAW's net income for the last quarter is -2.61B USD.

What is the 5 year returns of TRAW?

chevron-up
The 5 year returns of TRAW is -99.45% as on 9 Oct '26.

What is the high & low stock price of TRAW today?

chevron-up
TRAW stock price hit a high of $0.48 and low of $0.47 as of 9 Oct '26.

Can I buy TRAW shares in India?

chevron-up
Yes. You can buy TRAW in India by opening an international trading account.